PuraPharm Corporation Limited Stock Price

PuraPharm Corporation Limited, an investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac brand names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong’s name that provide Chinese medicine services and CCMG products. In addition, the company engages in the plantation and trading of raw Chinese herbs; manufacture and sale of traditional Chinese medicine decoction pieces; provision of modernized Chinese medicine services, Chinese medical diagnostic services; and research and development of bio-based polymeric materials. It sells its products to hospitals, healthcare institutions, mobile clinics, and medicine practitioners, as well as operates an online platform. PuraPharm Corporation Limited was incorporated in 1998 and is headquartered in Tai Po, Hong Kong.